2018 - 3 Issue

Case report

Congentinal Central Toxoplasma Chorioretinitis - Case Study

Full Text links

Summary

Congenital toxoplasmosis is a globally spread infectious disease caused by transplacental transmission of an intracellular parasitic protozoan Toxoplasma gondii. The infection can cause serious multi-organ complications, and in the case of vertical transmission, can lead up to fetal death – depending on the stage of pregnancy at the time of infection and the overall condition of the mother’s immune system. Chorioretinitis, hydrocephalus and intracranial calcifications are a typical triad of symptoms associated with the disease. Toxoplasmic chorioretinitis in particular is the most common ocular manifestation. If the central retina is affected, it can cause a severe impairment of central visual acuity or lead up to blindness in the child. Prenatal screening of this disease is presently voluntary in the Czech Republic. This article reports on a case study of a toxoplasmic chorioretinitis in a newborn child observed from the active stage and the development of the affected retina over time. Further is also reported on the diagnostics and the treatment of multi-organ complications which occurred in this patient. Ophthalmologic examination was performed after diagnosis of hydrocephalus, which revealed severe changes of retina. Hydrocephalus was then properly treated. An overview of the diagnostic and therapeutic methods and the screening options available in the Czech Republic compare with other countries is also presented in the report.

References

  1. Bischoff, A.R., Friedrich, L., Cattan, J.M. et al.: Incidence of Symptomatic Congenital Toxoplasmosis During Ten Years in a Brazillian Hospital. Pediatr Infect Dis J, 35; 2016: 1313-1316.
  2. Boyer, K., Hill, D., Mui, E. et al.: Unrecognized Ingestion of Toxoplasma gondii Oocysts Leads to Congenital Toxoplasmosis and Causes Epidemics in North America. CID, 53; 2011: 1081-1089.
  3. Faucher, B., Garcia-Meric, P., Franck, J., et al.: Long-term ocular outcome in congenital toxoplasmosis: A prospective kohort of treated children. J Infect, 64; 2012:104-109.
  4. Geleneky, M., Prášil, P., Kodym, P.: Doporučený postup pro diagnostiku a léčbu toxoplasmózy [online]. Schváleno výborem Společnosti infekčního lékařství ČLS JEP v červnu 2017, datum vydání 7. listopadu 2017. Dostupné na WWW: < https://www.infekce.cz/DoporToxo17. htm >.
  5. Guha, R., Miley, L., Aspiri M. et al.: Con - genital Toxoplasmosis. Pediatr Neurol, 70; 2017: 81-82.
  6. Handl, V.K., Klingelhöfer, D., Schlöffel, N. et al.: Kongenitale Toxoplasmose und Toxoplasma gondii. Zbl Arbeitsmed, 66; 2016: 239-248.
  7. In Pepose J.S., Holland, G.H., Wilhalmus, K.R.: Ocular Infection Immunity. Mosby, St.Lois, 1996, p. 1183-1224.8.
  8. Janků, J.: Pathogenesa a patologická anatomie tak nazvaného vrozeného kolobomu žluté skvrny v oku normálně velikém a mikrophtalmickém s nálezem parasitů v sítnici.Cas Lek Ces, 62; 1923: 1021-1027.
  9. Janku J.: Die patogenese ung patho - logishe Anatomie des sogenannten angeborenen Koloboms des gelben Fleckes im normal grossen sowie im mikrophthalmishen Auge mit Parasitenbefund in der Netzhaut. Cls Parasit, 6; 1959: 9-16.
  10. Kartasasmita, A., Muntur, W.P., Enus, S. et al.: Rapid resolution of toxoplasma chorioretinitis treatment using quadruple therapy. Clin Ophthalmol, 11; 2017: 2133-2137.
  11. Korol, A.R., Zborovska, O., Kustryn, T. et al.: Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol, 11; 2017: 1315-1320.
  12. Melamed, J., Eckert, G.U., Spadoni, V.S. et al.: Ocular manifestations of congenital toxoplasmosis. Eye, 24; 2010: 528-534.
  13. Modrzejewska, M., Patalan, J., Kulik, U. et al.: Ocular manifestation of congenital toxoplasmosis, clinical implication – case report. Ginekol Pol, 87; 2016:226- 230.
  14. Paulová M., Vignerová J., Riedlová J.: Individuální hodnocení růstu pomocí růstových grafů se zaměřením na děti do 2 let. Neonatologické listy 15; 2009: 3-9.
  15. Prusa, A-R., Kasper, D.C., Sawers, L. et al.: Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving. PloS Negl Trop Dis. 2017, č. 11 [cit. 2017-04-21]. Dostupný na WWW: < http://doi.org/10.1371/journal.pntd.0005648 >.
  16. Rishi P.,Venkataraman A., Rishi E.: Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis. Indian J Ophthalmol. 2011;59(1):62-64.
  17. Robert-Gangneux, F., Dard M.-L.: Epi - demiology of and Diagnostic Strategies for Toxoplasmosis. Clin Microbiol Rev. 2012 Apr; 25(2): 264–296.
  18. Rothova, A., Meenken, C., Buitenhuis, H.J. et al.: Therapy for Ocular Toxoplasmosis. Am J Ophthalmol, 115; 1993:517-523.
  19. Sahinoglu-Keskek, N., Unal F., Cevher, S. et al.: Cause of visual impairment in patiens with ocular toxoplasmosis. J Infect dev Ctries, 11; 2017:192-195.
  20. Shah NJ, Shah UN.: Intravitreal ranibi - zumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis. Indian J Ophthalmol. 2011;59(4):318-319.
  21. Smit, S.A., Padalko, E., Acker, J.V. et al.: Public Health Impact of Congenital Toxoplasmosis and Cytomegalovirus Infection in Belgium, 2013: A Systematic Review and Data Synthesis. CID, 20; 2017: 1-8.
  22. Souza, C.E., Nascimento, H., Lima, A. et al.: Intravitreal Injection of Sulfametoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis. Ocul Immunol Inflamm, 00; 2017:1-4.
  23. Surveillance Atlas of Infectious Diseases. Dataset provided by ECDC based on data - provided by WHO and Ministries of Health from the affected countries. Dostupné na WWW: < http://atlas. ecdc.europa.eu/public/index.aspx >.
  24. Wallon, M., Garweg, J.G., Abrahamowicz, M. et al.: Ophthalmic Outcomes of Congenital Toxoplasmosis Followed Until Adolescence. Pediatrics, 133; 2014: e601-e608. 25.. Wallon, M., Peyron, F.: Congenital Toxoplasmosis: A Plea for a Neglected Disease. Pathogens, 7; 2018: 25.
  25. Zamora, Y.F., Arantes, T., Reis, F.A. et al.: Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone. Arq Bras Oftalmol, 78; 2015: 216-219.